We report a comprehensive analysis of the prevalence of BRCA1 and BRCA2 germline mutations in Pakistani patients with TNBC and non-TNBC selected for age of onset or family history of breast/ovarian cancer. This evidence concerns the gene BRCA1 and ovarian cancer.